🔎 Trials Near Me

Akèy › Karsinòm selil skuamèz tèt ak kou › Georgia › Atlanta

Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan Atlanta, GA

24 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan ak bò kote Atlanta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Ap rekriteFaz 1
  • Emory University, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Ap rekriteFaz 3
  • Emory University, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07276399

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

Ap rekriteFaz 2
  • Emory University Hospital Midtown, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06980038

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Ap rekriteFaz 3
  • Emory University Hospital Midtown, Atlanta
Laj 60 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04892173

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 1
  • Emory University, Atlanta
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT07219212

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 2
  • Emory Proton Therapy Center, Atlanta
  • Emory University Hospital Midtown, Atlanta
Laj 18 a 79 · Tout sèks · Mizajou Sep 22, 2026 · NCT04671667

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Ap rekriteFaz 2
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Ap rekriteEtid obsèvasyon
  • Morehouse, Atlanta
  • Piedmont Healthcare, Atlanta
  • Winship Cancer Institute, Emory University, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06163534

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 2
  • Emory University School of Medicine, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06769698

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Ap rekriteFaz 2/3
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04333537

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Ap rekriteFaz 1/2
  • Winship Cancer Institute - Emory University, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Emory University, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT03526835

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Ap rekrite
  • Emory Midtown University Hospital/Winship Cancer Institute, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT06662058

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Winship Cancer Institute, Emory University, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 3
  • GSK Investigational Site, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT06256588

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 2
  • USA10-0, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06953089

Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial

Ap rekrite
  • Emory University Hospital, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT07203911

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 3
  • Emory University, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Apr 9, 2026 · NCT06064877

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Research Site 111, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Apr 6, 2026 · NCT05785741

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Ap rekriteFaz 1
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Mar 4, 2026 · NCT06868433

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Ap rekriteFaz 2
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Feb 11, 2026 · NCT06636734

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Research Site 114, Atlanta
  • Research Site 139, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05914116

A Beta-only IL-2 ImmunoTherapY Study

Ap rekriteFaz 1/2
  • Emory - Winship Cancer Institute, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2025 · NCT05086692

Etid Karsinòm selil skuamèz tèt ak kou nan lòt vil

Lòt etid nan Atlanta

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.